To assess predisposing factors in patients of mucormycosis following COVID infection at a tertiary hospital in North India

Completed

• Conditions: Coronavirus as the cause of diseases classified elsewhere, (2) ICD-10 Condition: B463||Cutaneous mucormycosis, (3) ICD-10 Condition: B464||Disseminated mucormycosis, (4) ICD-10 Condition: B465||Mucormycosis, unspecified, (5) ICD-10 Condition: B461||Rhinocerebral mucormycosis,

• Registration Number: CTRI/2021/10/037466
• Lead Sponsor: NITIKA BERI

Brief Summary

A surge of cases of Mucormycosis post second wave of Covid -19 has been seen in India. Through this questionnaire based study we aim to assess the predisposing factors of Mucormycosis to prevent another epidemic to black fungus in India.

Detailed Description

Not available

Study Timeline

• Study Start: 2021-10-30
• Study Completion: 2021-11-30
• Last Update Posted: 2023-08-01

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

Patients with Mucormycosis admitted at the tertiary care center.

Exclusion Criteria

Patients without Mucormycosis admitted at the hospital and patients who do not give consent to be a part of the study.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To assess predisposing factors for Mucormycosis	At baseline

Secondary Outcome Measures

Name	Time	Method
Association of severity of disease with predisposing factors.	At baseline

Trial Locations

Locations (1)

University College of Medical Sciences And GTB Hospital; 🇮🇳 East, DELHI, India

University College of Medical Sciences And GTB Hospital

🇮🇳East, DELHI, India

DR NITIKA BERI

Principal investigator

9871130760

berinitika@gmail.com